Portal de Periódicos da CAPES

Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD

2022; Lippincott Williams & Wilkins; Volume: 76; Issue: 5 Linguagem: Inglês

10.1002/hep.32324

1527-3350

Mary P. Moore, Rory P. Cunningham, Grace M. Meers, Sarah A. Johnson, Andrew A. Wheeler, Rama Ganga, Nicole Spencer, J. Benjamin Pitt, Alberto A. Diaz‐Arias, Ahmed Swi, Ghassan M. Hammoud, Jamal A. Ibdah, Elizabeth J. Parks, R. Scott Rector,

Diet, Metabolism, and Disease

NAFLD and its more-advanced form, steatohepatitis (NASH), is associated with obesity and is an independent risk factor for cardiovascular, liver-related, and all-cause mortality. Available human data examining hepatic mitochondrial fatty acid oxidation (FAO) and hepatic mitochondrial turnover in NAFLD and NASH are scant.To investigate this relationship, liver biopsies were obtained from patients with obesity undergoing bariatric surgery and data clustered into four groups based on hepatic histopathological classification: Control (CTRL; no disease); NAFL (steatosis only); Borderline-NASH (steatosis with lobular inflammation or hepatocellular ballooning); and Definite-NASH (D-NASH; steatosis, lobular inflammation, and hepatocellular ballooning). Hepatic mitochondrial complete FAO to CO2 and the rate-limiting enzyme in β-oxidation (β-hydroxyacyl-CoA dehydrogenase activity) were reduced by ~40%-50% with D-NASH compared with CTRL. This corresponded with increased hepatic mitochondrial reactive oxygen species production, as well as dramatic reductions in markers of mitochondrial biogenesis, autophagy, mitophagy, fission, and fusion in NAFL and NASH.These findings suggest that compromised hepatic FAO and mitochondrial turnover are intimately linked to increasing NAFLD severity in patients with obesity.